Alloplant
Pseudo-scientific "regenerative" compound biomaterial which is made from cadaver tissues "by using a complicated technology" claiming to have less rejection rate. Different types of Alloplant presumably should stimulate the growth of blood vessels, lymphatic vessels, bone, sclera of the eye, transparent cornea, etc.
It is claimed that 83 types of Alloplant are produced in the Russian Eye and Plastic Surgery Centre. Alloplant was never properly tested and/or approved by FDA or CDC or other governmental body in the US.
Use in eye transplant[]
The primary advocate of alloplants is the Russian surgeon . In 2000, he claimed to have successfully transplanted a human eye onto a blind woman using a harvested cornea and retina combined with an alloplant.
The operation happened after he and his colleagues made a trip to Tibet. According to Muldashev, this voyage gave him an innate and unprecedented understanding of certain worldly ideas and concepts maintain that such transplants are medically impossible and not supported by peer-reviewed medical evidence. Nevertheless, the patient in question claims to have developed the ability to distinguish shapes, colors, and even letters with her transplanted eye.[1] Two ophthalmologists from Nevada published a paper in 2008 concluding that the alloplant method reduced intraocular pressure, one of the main ways of treating glaucoma, and assisted tissue regeneration.[2]
References[]
 | This medical treatment–related article is a stub. You can help Wikipedia by . |
- Transplantation medicine
- Tissues (biology)
- Medical treatment stubs